Imatib 400 mg is a high-dose oral formulation of imatinib mesylate—a selective tyrosine kinase inhibitor that targets BCR‑ABL, c‑KIT, and PDGFR. It is indicated for adult patients with chronic myeloid leukemia (CML), Philadelphia chromosome‑positive acute lymphoblastic leukemia (Ph+ ALL), and c‑KIT positive gastrointestinal stromal tumors (GIST), especially in advanced or resistant disease settings. By inhibiting these kinases, Imatib disrupts cancer cell signaling to help achieve disease control.
Select options
This product has multiple variants. The options may be chosen on the product page
Primary superficial basal cell carcinoma (when surgery isn’t suitable)
External genital and perianal warts (from HPV) in individuals 12 years and older
It works by stimulating the body’s immune system to produce cytokines (e.g. interferon‑α) that help clear abnormal or infected cells. The cream is applied to the affected skin and left for several hours to trigger a local response.
Select options
This product has multiple variants. The options may be chosen on the product page
Lenalid 10 mg is a prescription cancer medication containing Lenalidomide, widely used for treating multiple myeloma, myelodysplastic syndromes, and mantle cell lymphoma. It works by enhancing the immune response and stopping the growth of abnormal cancer cells. This capsule is part of a class of drugs called immunomodulatory agents, designed to give cancer patients a better quality of life and improved prognosis.
Select options
This product has multiple variants. The options may be chosen on the product page
Lenalid 15 mg is a powerful oral capsule containing Lenalidomide, primarily prescribed for the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and certain forms of lymphoma. It belongs to the class of immunomodulatory drugs, which work by modifying immune responses and slowing the growth of abnormal cells. With strong anticancer activity, Lenalid 15 mg offers essential support for patients undergoing cancer treatment.
Select options
This product has multiple variants. The options may be chosen on the product page
Lenalid 25 mg is a high-dose cancer care capsule containing Lenalidomide, used primarily to treat multiple myeloma, myelodysplastic syndromes (MDS), and mantle cell lymphoma. It works by stimulating the immune system, suppressing abnormal cells, and slowing the growth of cancer. Lenalid 25 mg is typically part of combination therapy but may also be prescribed alone based on the patient’s condition and response.
Select options
This product has multiple variants. The options may be chosen on the product page
Lenalid 5 mg is a low-dose oral capsule containing Lenalidomide, used to manage and treat multiple myeloma, myelodysplastic syndromes (MDS), and certain lymphomas. It works by enhancing immune activity and reducing abnormal cancer cell growth. This lower dose is often prescribed for patients needing milder therapy or as part of a long-term maintenance treatment strategy.
Select options
This product has multiple variants. The options may be chosen on the product page
Letrozole 2.5 mg is a non‑steroidal aromatase inhibitor prescribed primarily for postmenopausal women with hormone receptor‑positive breast cancer. By inhibiting the aromatase enzyme, it significantly lowers estrogen production—helping to slow tumor growth and reduce the risk of recurrence. It’s commonly used as adjuvant therapy after surgery or as first-line treatment for advanced disease
Select options
This product has multiple variants. The options may be chosen on the product page
Lupride 1 mg Injection contains leuprolide acetate, a synthetic GnRH agonist used to suppress hormone production by desensitizing the pituitary gland over time. It is widely utilized in:
Prostate cancer (medical castration in advanced or metastatic disease)
Endometriosis and uterine fibroids (to reduce hormone-fueled growth and alleviate symptoms)
Central precocious puberty (to delay early onset puberty in children)
Typically administered as a short course, Lupride disrupts natural hormone cycles, reducing estrogen or testosterone levels effectively under clinician monitoring.
Select options
This product has multiple variants. The options may be chosen on the product page
Lupride Depot 22.50 mg is a sustained-release depot injection containing leuprorelin acetate, a GnRH (gonadotropin-releasing hormone) agonist. Administered intramuscularly, it provides continuous hormone modulation over three months. It’s used under medical supervision to reduce sex hormone levels, helping manage conditions such as advanced prostate cancer, endometriosis, uterine fibroids, and central precocious puberty in children.
Select options
This product has multiple variants. The options may be chosen on the product page
Resihance 40 mg contains regorafenib, an oral multi‑kinase inhibitor targeting angiogenic, stromal, and oncogenic tyrosine kinases. It is approved as a later‑line treatment for:
Metastatic colorectal cancer after prior chemotherapy and targeted agents
Advanced gastrointestinal stromal tumors (GIST) refractory to imatinib and sunitinib
Hepatocellular carcinoma (HCC) in patients previously treated with sorafenib
Regorafenib works by blocking kinase pathways essential for tumor growth and blood vessel formation, aiding in slowing disease progression.
Select options
This product has multiple variants. The options may be chosen on the product page
Spexib 150 mg is an oral capsule containing ceritinib, a potent ALK (anaplastic lymphoma kinase) inhibitor designed for the treatment of ALK‑positive advanced or metastatic non‑small cell lung cancer (NSCLC). It’s effective for patients who have failed or cannot tolerate crizotinib, offering improved control over certain resistant ALK mutations. Spexib targets tumor-driving pathways, helping slow progression and extending survival in molecularly defined patient populations.
Select options
This product has multiple variants. The options may be chosen on the product page
Tamoxifen 10 mg is a selective estrogen receptor modulator (SERM) widely prescribed for treating and preventing estrogen receptor–positive breast cancer. It works by blocking estrogen in breast tissue, slowing tumor growth and reducing recurrence risk. Each tablet contains 10 mg of tamoxifen (equivalent to 15.2 mg tamoxifen citrate). It is typically taken once daily and may be used for several years depending on treatment goals.
Select options
This product has multiple variants. The options may be chosen on the product page
End of content
End of content
Join our newsletter and get 20% off your first order
Subscribe to our newsletter and get the latest trending products and offers updates.
Wait! before you leave…
We have something special for you
Use above code to get 20% off for your first order when checkout. Don't miss it.
In order to provide you a personalized shopping experience, our site uses cookies. By continuing to use this site, you are agreeing to our cookie policy.
